Director Alex Gibney explores how Purdue Pharma worked closely with the FDA to approve OxyContin for widespread use, touting its safety without evidence and campaigning to redefine pain treatment. In the face of insufficient government intervention, Purdue continued to prioritize profit over addiction, creating a market for even deadlier opioids.
Shining a spotlight on the mass marketing of the synthetic opioid fentanyl and examining the connections between drug manufacturers and government policy.
Alex Gibney
Director
Nancy Abraham
Producer
Aaron Fishman
Lisa Heller
Todd Hoffman